Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia

Phase 3

Completed

• Conditions: Anemia of Pregnancy
• Interventions: Dietary Supplement: Moringa oleifera capsules; Dietary Supplement: iron and folic acid supplements

• Registration Number: NCT05737862
• Lead Sponsor: Universitas Padjadjaran

Brief Summary

The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-01
• Primary Completion: 2022-06-30
• Study Completion: 2022-07-30
• Study First Submitted: 2023-02-10
• Study First Submitted QC: 2023-02-10
• Study First Posted: 2023-02-21
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-06
• Last Update Posted: 2023-03-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Pregnant women with 2nd and 3rd trimester of pregnancy
• Pregnant women with mild to moderate anemia At day 90 after treatment

Exclusion Criteria :

• Hypotensive pregnant women
• Pregnant women with Gemelli
• Pregnant women with chronic diseases (hepatitis and HIV)

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Moringa oleifera leaf capsule	Moringa oleifera capsules	Subjects in this arm receive experimental capsules containing powdered Moringa oleifera leaf capsules along with IFA tablets
Moringa oleifera leaf capsule	iron and folic acid supplements	Subjects in this arm receive experimental capsules containing powdered Moringa oleifera leaf capsules along with IFA tablets
Iron and folic acid capsule	iron and folic acid supplements	Subjects in this arm only receive iron and folic acid (IFA) tablets

Primary Outcome Measures

Name	Time	Method
Changes in Haemoglobin (Hb) level	Day 0 and day 30	Hb will be meassured twice, before treatment and 30 days after treatment

Trial Locations

Locations (1)

University Padjajaran; 🇮🇩 Bandung, West Java, Indonesia